Antioxidative response for nitric oxide production in breast carcinoma

Oncology Reports

Volumn 12, Issue 4, 2004, Pages 755-759

  Karihtala, Peeter ^a   Kinnula, Vuokko L ^b   Soini, Ylermi ^a  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Antioxidative enzyme; Breast cancer; Nitric oxide synthase; Nitrotyrosine; Vascular endothelial growth factor

Indexed keywords

3 NITROTYROSINE; 3-NITROTYROSINE; CATALASE; DRUG DERIVATIVE; ISOPROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDIZING AGENT; SCAVENGER; SUPEROXIDE DISMUTASE; TYROSINE; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; BREAST TUMOR; CARCINOMA; COLLOID CARCINOMA; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PAPILLARY CARCINOMA; PATHOLOGY;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, PAPILLARY; CATALASE; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; MIDDLE AGED; NEOPLASMS, DUCTAL, LOBULAR, AND MEDULLARY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN ISOFORMS; SUPEROXIDE DISMUTASE; TYROSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 16644376060     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.4.755     Document Type: Article

References (34)

1. Palmer RMJ, Ferrige AG and Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987. (Pubitemid 17085822)
2. Ignarro LJ, Buga GM, Wood KS, Byrns RE and Ghaudhuri G: Endothelial-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269, 1987.
3. Wiseman H and Halliwell B: Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313: 17-29, 1996. (Pubitemid 26013419)
4. Haddad IY, Ischiropoulos H, Holm BA, Beckman JS, Baker JR and Matalon S: Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol 265: 555-564, 1993.
5. Radi R, Rodriguez M, Castro L and Telleri R: Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 308: 89-95, 1994. (Pubitemid 24172608)
6. Chazotte-Aubert L, Hainaut P and Ohshima H: Nitric oxide nitrates tyrosine residues of tumor-suppressor p53 protein in MCF-7 cells. Biochem Biophys Res Commun 267: 609-613, 2000. (Pubitemid 30076846)
7. Davis KL, Martin E, Turko IV and Murad F: Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol 41: 203-236, 2001. (Pubitemid 32385888)
8. Karihtala P, Mantyniemi A, Kang SW, Kinnula VL and Soini Y: Peroxiredoxins in breast carcinoma. Clin Cancer Res 9: 3418-3424, 2003. (Pubitemid 37082738)
9. Nathan C and Xie QW: Regulation of biosynthesis of nitric oxide. J Biol Chem 269: 13725-13728, 1994. (Pubitemid 24191108)
10. Lala PK and Chakraborty C: Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol 2: 149-156, 2001. (Pubitemid 33585926)
11. Gasparini G: Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist 5: 37-44, 2000.
12. Toi M, Kondo S, Suzuki H, et al: Quantitative analysis of vascular endothelial growth factor in primary breast cancer. Cancer 77: 1101-1106, 1996. (Pubitemid 26080900)
13. Gasparini G: Clinical significance of determination of surrogate markers of angiogenesis in breast cancer. Crit Rev Oncol Hematol 37: 97-114, 2001.
14. Samoszu M, Brennan ML, To V, Leonor L, Zheng L, Fu X and Hazen SL: Association between nitrotyrosine levels and microvascular density in human breast cancer. Breast Cancer Res Treat 74: 271-278, 2002. (Pubitemid 34848354)
15. Vakkala M, Kahlos K, Lakari E, Paakko P, Kinnula V and Soini Y: Inducible nitric oxide synthase expression, apoptosis and angiogenesis in in situ and invasive breast carcinomas. Clin Cancer Res 6: 2408-2416, 2000. (Pubitemid 30399209)
16. Elston CW and Ellis IO (eds): Classification of malignant breast disease. In: The Breast Systemic Pathology. Churchill Livingstone, Edinburgh, pp239-247, 1998.
17. Calmels S, Hainaut P and Ohshima H: Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer Res 57: 3365-3369, 1997. (Pubitemid 27355476)
18. Ekmekcioglu S, Ellerhorst J, Smid CM, Prieto VG, Munseli M, Buzaid AC and Grimm EA: Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin Cancer Res 6: 4768-4775, 2000. (Pubitemid 32110418)
19. Kato H, Miyazaki T, Yoshikawa M, et al: Expression of nitrotyrosine is associated with angiogenesis in esophageal squamous cell carcinoma. Anticancer Res 21: 3323-3329, 2001. (Pubitemid 34224234)
20. Ehsan A, Sommer F, Schmidt A, et al: Nitric oxide pathways in human bladder carcinoma. The distribution of nitric oxide synthases, soluble guanylyl cyclase, cyclic guanosine monophosphate and nitrotyrosine. Cancer 95: 2293-2301, 2002. (Pubitemid 35351134)
21. Kondo S, Toyokuni S, Tsuruyama T, et al: Peroxynitrite-mediated stress is associated with proliferation of human metastatic colorectal carcinoma in the liver. Cancer Lett 179: 87-93, 2002. (Pubitemid 34195657)
22. Broholm H, Braendstrup O and Lauritzen M: Nitric oxide synthase expression of oligodendrogliomas. Clin Neuropathol 20: 233-238, 2001. (Pubitemid 33081705)
23. Yagihashi N, Kasajima H, Sugai S, et al: Increased in situ expression of nitric oxide synthase in human colorectal cancer. Virchows Arch 436: 109-114, 2000. (Pubitemid 30128756)
24. Broholm H, Rubin I, Kruse A, Braendstrup O, Schmidt K, Skriver EB and Lauritzen M: Nitric oxide synthase expression and enzymatic activity in human brain tumors. Clin Neuropathol 22:273-281, 2003. (Pubitemid 37541366)
25. Li Y, Huang T-T, Carlson EJ, et al: Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11: 376-381, 1995.
26. Lebovitz RM, Zhang H, Vogel H, et al: Neurodegeneration, myocardial injury and perinatal death in mitochondrial superoxide dismutase-deficient mice. Am J Respir Cell Mol Biol 19: 114-120, 1998.
27. Wong GH: Protective roles of cytokines against radiation: induction of mitochondrial MnSOD. Biochim Biophys Acta 1271: 205-209, 1995.
28. Abid MR, Tsai JC, Spokes KC, Deshpande SS, Irani K and Aird WC: Vascular endothelial growth factor induces manganese-superoxide dismutase expression in endothelial cells by a Rac1-regulated NADPH oxidase-dependent mechanism. FASEB J 15: 2548-2550, 2001.
29. Bianchi A, Becuwe P, Franck P and Dauca M: Induction of MnSOD gene by arachidonic acid is mediated by reactive oxygen species and p38 MAPK signaling pathway in human HepG2 hepatoma cells. Free Radic Biol Med 32: 1132-1142, 2002. (Pubitemid 34603351)
30. Zhang HJ, Zhao W, Venkataraman S, Robbins ME, Buettner GR, Kregel KC and Oberley LW: Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species. J Biol Chem 277: 20919-20926, 2002. (Pubitemid 34967401)
31. Punnonen K, Ahotupa M, Asaishi K, Hyoty M, Kudo R and Punnonen R: Antioxidant enzyme activities and oxidative stress in human breast cancer. J Cancer Res Clin Oncol 120: 374-377, 1994. (Pubitemid 24101438)
32. El-Bouhtoury F, Keller JM, Colin S, Parache RM and Dauca M: Peroxisomal enzymes in normal and tumoral human breast. J Pathol 166: 27-35, 1992.
33. Ray G, Batra S, Shukla NK, Deo S, Raina V, Ashok S and Husain SA: Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat 59: 163-170, 2000. (Pubitemid 30216139)
34. Rzymowska J and Dyrda Z: Enzyme activities and level of SH groups in breast carcinomas. Int J Biochem 25: 1331-1334, 1993. (Pubitemid 23263086)